-
Study aim
-
To evaluate the maggot therapy on 3rd burning ulcers on volunteer patients in Shahid Motahhari Hospital of Tehran
-
Design
-
A randomized design will conduct in this study. Six possible arrangements of A and B will type on six cards including AABB, ABBA, BBAA, ABAB, BABA, BAAB. All cards will put in a box with shuffling. Dice will select a card for each time of categorizing. After 6 time of categorizing the 24 cases will categorize as control or treatment group. Character A and B will allocate to control and treatment groups respectively.
-
Settings and conduct
-
This is a clinical trial study with 56 patients who will refer to Motahhari Hospital. Patients must sign an informed consent form before entering the study. Blinding will not be done in this study.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Having at least one burning ulcer (3rd) with bacterial infection, lake of other sever disease such as heart, kidney or lung disorders, no need to use anticoagulants and or steroid pharmaceutics, no addiction with alcohol or opiums, no entomophobia
Exclusion criteria: Appearing of sever diseases such as heart, kidney or lung disorders, having un-controlled fever, having sever pain and bleeding during treatment.
-
Intervention groups
-
Patients entered into the study will assign into two groups, control and intervention. Both groups will take routine treatments for burning ulcers and their related pharmaceutics. Routine therapy involves local and systemic measures, including surgery, debridement, various kinds of dressing, nutritional support, and antibiotic therapy. Patients in the intervention group, in addition to routine therapies, will receive maggot therapy as a method along with routine methods. Patients in the control group will be treated with routine methods only.
-
Main outcome variables
-
Reducing necrotic tissues and increasing of granulated tissues